Litcius/Paper detail

1077MO Adjuvant nivolumab v placebo in stage IIB/C melanoma: 3-year results from CheckMate 76K

G.V. Long, M. Del Vecchio, Christoph Höeller, Jeffrey S. Weber, J.J. Grob, Peter Mohr, Stephan Grabbe, C. Dutriaux, V. Chiarion Sileni, Jacek Mackiewicz, P. Rutkowski, Petr Arenberger, G. Quéreux, Tarek Meniawy, P.A. Ascierto, Janis M. Taube, A. Nassar, Wenshi Wang, J.M. Kirkwood

2024Annals of Oncology14 citationsDOIOpen Access PDF

Topics & Concepts

MedicineNivolumabAdjuvantPlaceboInternal medicineOncologyMelanomaImmunotherapyCancer researchCancerPathologyAlternative medicineCancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and ManagementMelanoma and MAPK Pathways
1077MO Adjuvant nivolumab v placebo in stage IIB/C melanoma: 3-year results from CheckMate 76K | Litcius